Stock-based compensation. (Details) - Schedule of option activity - $ / shares shares in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Schedule of option activity [Abstract] | ||
| Number of Shares, Outstanding at beginning of year | 229 | 229 |
| Weighted Average Exercise Price, Outstanding at beginning of year | $ 4.15 | $ 4.15 |
| Number of Shares, Options exercised | (22) | |
| Weighted Average Exercise Price, Options exercised | $ 3.74 | |
| Number of Shares, Outstanding at end of year | 207 | 229 |
| Weighted Average Exercise Price, Outstanding at end of year | $ 4.16 | $ 4.15 |
| Number of Shares, Options exercisable at end of year | 207 | 229 |
| Weighted Average Exercise Price, Options exercisable at end of year | $ 4.16 | $ 4.15 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|